Potential New Way To Make A Good Anti-leukemia Drug Even Better

A recently identified cancer-causing protein makes the anti-leukemia drug imatinib, less effective. By blocking the protein, researchers were able to slow the spread of leukemia cells in culture. The study, which will appear in the Journal of Experimental Medicine, suggests that the most effective treatment for leukemia may rely on a combination of targeted drugs, rather than a single miracle drug.

Read the whole article on Science Daily

More from Science Daily